AN
ANTI.US Antigenics Inc
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is ANTI.US undervalued?
Graham numberThe Graham number of Antigenics Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Antigenics Inc fundamental analysis
No fundamental analysis for Antigenics Inc yet.
Antigenics Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Antigenics Inc
Antigenics, Inc., a clinical-stage biopharmaceutical company, discovers, manufactures, and develops immunotherapies for cancer. The company was founded in 1994 and is based in Lexington, Massachusetts.
Full company profileFinancial statements of Antigenics Inc are not available yet.
Antigenics Inc dividends
Antigenics Inc has not paid dividends in the last 1 fiscal years.
Who owns Antigenics Inc
Ownership data of Antigenics Inc is not available yet.
Antigenics Inc company profile
- Company name
- Antigenics Inc
- Ticker
- ANTI.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Biotechnology
- Address
- 3 Forbes Road, Lexington, MA, United States, 02421-7305
- Phone
- 781 674 4400
- Website
- agenusbio.com
About Antigenics Inc
Antigenics, Inc., a clinical-stage biopharmaceutical company, discovers, manufactures, and develops immunotherapies for cancer. The company was founded in 1994 and is based in Lexington, Massachusetts.